The effects of Thalamonal on cerebral circulation and oxygen consumption were studied in ten normal healthy patients before operations. After the administration of Thalamonal 0.1 ml/kg, cerebral blood flow (c.b.f.) and Pa^ increased from a control value of 48+4.2 to 51 + 3.9 ml/100 g/min and from 34.6 ±1.2 to 37.1 + 1.8 mm Hg, respectively, but these were not statistically significant changes. Oxygen consumption (CMRo 2 ) increased from a control value of 3.06 + 0.22 to 3.08 ±0.30 ml/100 g/min during neuroleptanalgesia with Thalamonal, but this change was also not significant. It was concluded that Thalamonal had no significant effect on c.b.f. and CMRo 2 of man when Paco 2 was within normal limits and body temperature remained unchanged.
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There are conflicting reports regarding the effects of neuroleptanalgesia on cerebral circulation. Barker and co-workers (1968) found that regional blood flow in the cerebral hemisphere of man did not change significantly with droperidol and phenoperidine. Nilsson and Ingvar (1966) reported that both phenoperidine and fentanyl increased the blood flow in the cerebral cortex of cats, possibly as a result of increased cerebral oxygen consumption. Kreuscher (1965) , however, found that droperidol and fentanyl decreased the cerebral blood flow in dogs.
Such diverse discrepancy on the effects of neuroleptanalgesia on cerebral circulation prompted us to study the effects of Thalamonal (fentanyl citrate 0.05 mg and droperidol 2.5 mg per ml of solution) on the cerebral blood flow and oxygen consumption of man.
METHODS
This study was carried out on ten healthy patients who were undergoing elective operations and whose prior consent had been obtained. Preoperative examination revealed no cardiopulmonary and neurological disorders. Their average age and weight was 41 + 1.7 (SE) years and 49 + 2.3 (SE) kg, respectively.
Measurements of cerebral blood flow (c.b.f.) and oxygen consumption (CMRo 2 ) were performed before and during neuroleptanalgesia with Thalamonal. One hour after subcutaneous administration of atropine 0.5 mg, Thalamonal 0.1 ml/kg was given intravenously over 1 min; 2-3 min after Thalamonal, alcuronium 0.2 mg/kg was given intravenously to overcome muscle rigidity and at the same time assisted ventilation maintained normocarbia.
Rectal temperatures were measured with a calibrated thermistor probe. Teflon catheters were placed in the radial artery and in the internal jugular bulb for blood sampling and pressure measurement. During the entire period of study, about 300 ml of 5% pentose solution (xylitol) was given by intravenous drip and 85 ml of blood was removed for blood analyses which included glucose, lactate and pyruvate determinations in arterial and internal jugular venous blood, though the results are not presented and discussed in this paper. The subjects were unstimulated throughout the study.
While awake and 45 min after the administration of atropine, patients breathed 100% oxygen for 15 min and then inhaled a mixture of 10% nitrous oxide and 90% oxygen for c.b.f. measurement. In all the studies, c.b.f. was determined over a 14-min period. Simultaneous arterial and internal jugular blood samples were obtained at approximately 1, 3, 5, 7, 10 and 14 min following the onset of inhalation of nitrous oxide gas mixture. Concentration of nitrous oxide in the blood was determined by gas chromatography (Shimazu GC-4A-PTF). Sample vaporizing apparatus (Shimazu BGS-1A), Molecular Sieve 13X and a thermal conductivity detector were used (Okuda, 1968) . The coefficient of variance of the reproducibility was less than 3%. Cerebral blood flow was calculated by the Kety-Schmidt method. In this study, the amount of blood sampled by each route necessary for one c.b.f. measurement was 5-6 ml in total. Fifteen min after the control measurements Thalamonal was given and 5 min later c.b.f. measurements during analgesia were made.
During each c.b.f. measurement arterial and internal jugular venous pressures were measured 4 min after the start and immediately before the cessation of the 14-min inhalation of 10% nitrous oxide in oxygen. The difference between the mean arterial pressure and the internal jugular venous pressure measured by a water manometer with the zero point at the mastoid process was defined as cerebral perfusion pressure. Cerebral vascular resistance (c.v.r.) was calculated from perfusion pressure and c.b.f. Arterial and internal jugular venous blood were sampled simultaneously during each pressure measurement. Pa O2 , Pa C02 , pHa (arterial), JPv 02 , JPv C02 and Jp H v (internal jugular venous) were measured by an I-L meter (Model 113). Oxygen saturation and haemoglobin concentration were measured by an oxygen saturation meter (OSM-1) and a spectrophotometer (Hitachi 124 type), respectively. Oxygen content was determined as the sum of haemoglobin oxygen content and dissolved oxygen. In this study, if there was a change in Pa C o 2 of more than 2 mm Hg or in mean arterial pressure of more than 5 mm Hg during c.b.f. measurement, the data were discarded. Cerebral metabolic rates for oxygen (CMRo 2 ) was computed as the product of c.b.f. and arteriovenous oxygen content differences. All determinations except for c.b.f. were done in duplicate and the averages of the two sets were used for statistical analysis. Significance of difference for all mean values was tested by Student £ test for paired data. The results are presented as mean values with standard errors.
RESULTS (TABLE i)
Rectal temperatures averaged 36.5 + 0.2 and 36.8 + 0.3 °C in the waking state and during analgesia, respectively.
Thalamonal decreased the mean arterial pressure without significantly changing the internal jugular venous pressure. Therefore, cerebral perfusion pressure decreased from 86 ±4 to 72 + 3 mm Hg during analgesia; c.b.f. was 48 + 4.2 and 51 ±3.9 ml/100 g/min, in the waking and in the analgesic state, respectively. Table II (Reivich, 1964) . The difference between these mean values was not significant. Cerebral vascular resistance decreased from 1.89 + 0.16 to 1.47 + 0.10 mm Hg/ml/100 g/min, indicating cerebral vasodilatation. Pa O2 and JPv 02 did not change significantly. Pa 002 increased from 34.6 ±1.2 to 37.1 ±1.8 mm Hg during analgesia, though this increment was not statistically significant. The decrease in Pa C02 in the waking state seems to be due to hyperventilation which may be produced by the patient inhaling gas mixture with high concentration of oxygen and/or the patient's anxiety in response to the application of the face mask, in spite of adequate explanation of the procedure. With Thalamonal, CMRo 2 increased from the control value of 3.06 + 0.22 to 3.08 + 0.30 ml/100 g/min, but the change was not significant. In an analysis of the individual data, CMRo 2 increased in four patients, while it decreased in the other six. There was a significant change in arterial oxygen content. This may be the result of a decrease in haemoglobin concentration from 13.8 ±0.75 to 13.5+0.70 g/100 ml during analgesia. The addition of about 300 ml of fluid by infusion and the removal of 85 ml of blood during the two c.b.f. measurements can account for this magnitude of decrease in haemoglobin concentration. There was a significant change in pHa which was caused by both small and statistically insignificant increase of Paco, and decrease of base excess. Barker and associates (1968) reported that regional cerebral blood flow of grey matter at normocarbia measured by the xenon-133 clearance method was 87 ±24 (SD) ml/100 g/min during neuroleptanalgesia induced by droperidol 5 mg and phenoperidine 1.5 mg. This value did not differ significantly from the value obtained in normocarbic conscious man by Ingvar and associates (1965) . Wilkinson and Browne (1970) measured grey and white matter perfusion using the xenon-133 clearance technique and reported that there was a slight, but statistically insignificant, reduction from 86.6+17.1 to 77.3 + 16.9 (SD) ml/100 g/min in grey matter perfusion in patients anaesthetized with nitrous oxide and oxygen, supplemented by droperidol and phenoperidine, while white matter perfusion was very similar in the anaesthetized and conscious groups. However, they administered methohexitone 0.88 mg/kg about 1 hour before the c.b.f. measurement, therefore some residual effect of methohexitone on cerebral circulation cannot be ruled out.
DISCUSSION
In the present study, the method of c.b.f. measurement and the drugs and the dosages used were different from those used by the investigators cited above. In awake man, it has been generally accepted that the relationship of c.b.f. to Paco 2 (between 20 and 55 mm Hg) is nearly linear and that for each 1 mm Hg increase in Pa c02 the c.b.f. rises by about 1 ml/100 g/min (Reivich, 1964) . Therefore, it is perhaps more than coincidental that the 3 ml/100 g/min increase in mean c.b.f. observed in this study was accompanied by a 3 mm Hg increase in mean Pa C02 , suggesting that the cerebral vessels retained their normal sensitivity to alterations of Pa CO2 during analgesia. Wilkinson and Browne (1970) showed that hypocarbia (Pa CO2 =29 mm Hg) during neuroleptanaesthesia produced a remarkable decrease in c.b.f., suggesting that the cerebral vessels remained sensitive to Pa C02 alterations.
In awake man it is known that c.b.f. tends to remain constant when the mean arterial pressure ranges from 50 to 150 mm Hg (Lassen, 1959) . If this autoregulation in response to blood pressure alterations is operative throughout analgesia, c.b.f. should remain constant in spite of decreased perfusion pressure. The decreased c.v.r. observed in this study can be explained as the result of a small increase in Pa co . and of autoregulation following decreased cerebral perfusion pressure.
In animal experiments, Kreuscher (1965) showed a 50% reduction of both c.b.f. and cerebral metabolic rate in dogs after the administration of droperidol and fentanyl. Our data do not agree with his results. Species difference may exist. Freeman and Ingvar (1967) reported that the cortical blood flow of cats increased with increasing doses of fentanyl, accompanied by e.e.g. activation. However, it is well known that the effect of morphine and its related compounds on the central nervous system of cats is qualitatively different from the effect on man (Wilder, 1944) , therefore application of the results obtained from cats to man is largely limited.
Inhalational anaesthetics such as halothane (Wollman et al., 1964) or cyclopropane (Alexander et al., 1970) increase c.b.f. as anaesthesia deepens. As for intravenous anaesthetics, thiopentone (Pierce et al., 1962) decreases c.b.f. and ketamine (Takeshita et al., 1971) increases it. It is noteworthy that Thalamonal has no significant effect on c.b.f. in man, while the other commonly used anaesthetics affect it strikingly.
There was no significant or unidirectional change in CMRo 2 during analgesia. It had been generally accepted that CMRo, decreases in the anaesthetized state (Wollman, Alexander and Cohen, 1967) . Recent studies, however, revealed that CMRo, changes with various anaesthetics and with the depth of anaesthesia. Halothane, thiopentone and light cyclopropane decrease CMRo 2 while nitrous oxide and deep cyclopropane increase it (Theye and Michenfelder, 1968a; Cohen et al., 1964; Pierce et al., 1962; Altenburg, Michenfelder and Theye, 1969; Alexander et al., 1970) . Ketamine did not alter CMRo 2 significantly, but tended to decrease it (Takeshita, Okuda and Sari, 1971) . Theye and Michenfelder (1968b) stated that there was an apparent lack of correlation between the depth of anaesthesia and the metabolic rate, and thus cerebral oxygen consumption would not be a reliable index of actual cerebral function. In addition, unchanged CMRo 2 did not necessarily indicate that there was no change in cerebral respiration in various parts of the brain, since CMRo 2 measured in this study was apparently the overall mean of cerebral oxygen consumption. The relation between cerebral respiration and function awaits further study.
It has been demonstrated that volatile anaesthetics can produce a rise in cerebrospinal fluid pressure and that this rise is greatly augmented in patients with intracranial space-occupying lesions . The increased cerebrospinal fluid pressure due to anaesthetics was thought to be caused by the increased c.b.f. (McDowall, 1966) . Fitch and associates (1969) reported that droperidol and fentanyl produces a decrease in cerebrospinal fluid pressure and suggested that this is attributable to decreased c.b.f. with a possible reduction in the cerebral metabolic rate, although they did not actually measure c.b.f. and CMRo,. The present study did not clarify the relation between cerebrospinal fluid pressure and cerebral blood flow because the pressure was not measured. However, the assumption that the reduction in cerebrospinal fluid pressure during neuroleptanalgesia with droperidol and fentanyl is caused by decreased cerebral blood flow seems to be incompatible with the results reported here. 
RESUMEN
Fueron estudiados los efectos del talamonal sobre la circulacidn cerebral y consumo de oxigeno en diez pacientes con salud normal antes de la operacion. Despues de la administracion de 0,1 ml/kg de talamonal aumento el flujo sanguineo cerebral (CBF) y Paco 2 desde un valor de control de respectivamente 48 + 4,2 hasta 51 + 3,9 ml/100 gr/min y desde 34,6 + 1,2 hasta 37,1 + 1,8 mm Hg, pero estos cambios no fueron estadisticamente significativos. El cosumo de oxigeno (CMRo 2 ) aumento desde un valor de control de 3,06 + 0,22 hasta 3,08 + 0,30 ml/100 gr/min durante la neuroleptanalgesia con talamonal, pero este cambio no fue significative Se concluy6 que el talamonal no tenia efecto significativo sobre el CBF y CMRo 2 en el hombre cuando la Paco 2 estaba dentro de los limites normales y la temperatura corporal permanecia sin cambio.
